E231: Aileen Considine and Kate Burton - Life as a Consultant Therapeutic Radiographer
36 min
Trigger Warning: this episode discusses cancer and cancer treatment. Episode 231: Part of the Education and Workforce Development series (Part 83) Description: In this insightful episode, Naman Julka-Anderson and Jo McNamara sit down with Aileen Considine and Kate Burton. Aileen Considine is a Consultant Therapeutic Radiographer specialising in prostate cancer at Peterborough City Hospital. She trained as a Radiation Therapist at Trinity College Dublin, qualifying in 2009, and worked as a therapeutic radiographer in Dublin and Australia before moving to the UK in 2013 to join Peterborough City Hospital. She worked in dosimetry from 2014 to 2024 and completed a Master's in radiotherapy treatment planning at Sheffield Hallam University in 2020. While in dosimetry, Aileen began advanced practice in clinical target volume definition for prostate cancer, and she was appointed Consultant Therapeutic Radiographer in November 2024. Kate Burton is a Consultant Therapeutic Radiographer specialising in neuro-oncology at Cambridge University Hospitals. She qualified in 1992 and, after some years as a treatment radiographer, chose to specialise in radiotherapy for adult primary brain and spinal tumours. Her role developed first to advanced practice level, and in 2007 Kate was appointed as a Consultant Radiographer. Her main area of expertise is the radiotherapy management of benign skull base lesions, and she has published and presented on this subject and on the consultant radiographer role nationally and internationally. This episode is a deep dive into two very different routes into consultant practice, from a long-established post to one just over a year old, covering training and portfolio development, balancing the four pillars, autonomous clinical decision-making, communicating with patients, succession planning and living with imposter syndrome. CPD Reflection Points: Balancing the four pillars: Aileen described her week as around 80% clinical, while Kate explained...